Understanding Canine Brucellosis
Canine brucellosis is a serious bacterial infection that affects dogs worldwide, caused by the bacterium Brucella canis. This disease primarily impacts the reproductive system of dogs, leading to significant breeding difficulties and potential transmission risks. The infection can occur in both male and female dogs, causing devastating reproductive consequences that make breeding impossible. Understanding this disease is crucial for dog owners, breeders, and individuals considering adoption of potentially infected animals.
The disease is particularly concerning because it can persist indefinitely in infected animals and poses a potential zoonotic risk to humans, though human cases remain relatively rare. The bacterium is an intracellular pathogen, meaning it resides within cells, making treatment extremely challenging and often ineffective. Many veterinarians and regulatory agencies consider the disease essentially incurable in dogs, leading to difficult management and ethical decisions regarding infected animals.
Causes and Transmission
Brucella canis is transmitted primarily through direct contact with infected body fluids, particularly reproductive secretions. The most common transmission routes include:
- Vaginal and uterine discharges from infected females
- Seminal fluid and urinary secretions from infected males
- Placental tissue and fetal fluids during abortion
- Ingestion of infected tissues or contaminated environments
- Contact with infected urine and feces
Dogs can also acquire the infection through mucosal membranes, including oral, nasal, and conjunctival routes. Infected dogs may shed bacteria intermittently for extended periods, making quarantine and isolation procedures necessary to prevent spread to other animals. The bacteremia, or presence of bacteria in the bloodstream, typically appears between 2 to 4 weeks post-infection and can persist for approximately six months, becoming intermittent thereafter.
Clinical Signs and Symptoms
The clinical presentation of canine brucellosis varies considerably among infected dogs. Many dogs may exhibit no apparent symptoms, making detection challenging without diagnostic testing. When symptoms do appear, they primarily affect reproductive function and overall health.
Reproductive Signs in Females
Female dogs with brucellosis commonly experience:
- Late-stage abortion between 30 to 57 days of gestation
- Early embryonic death
- Infertility or reduced fertility
- Uterine infections (endometritis)
- Vaginal discharge and inflammation
- Failure to conceive despite normal estrous cycles
Reproductive Signs in Males
Male dogs infected with brucellosis typically present with:
- Infertility or reduced sperm production
- Enlarged or irritated scrotum
- Inflamed and painful testicles (orchitis)
- Testicular shrinkage and atrophy over time
- Epididymitis (inflammation of the epididymis)
- Prostatitis (inflammation of the prostate gland)
- Abnormal sperm morphology, including deformed acrosomes and coiled tails
General and Systemic Signs
Beyond reproductive issues, infected dogs may develop:
- Generalized lymphadenitis with enlarged lymph nodes
- Discospondylitis (spinal inflammation) causing back pain and lameness
- Uveitis (eye inflammation)
- Dry hair coat and poor skin condition
- Decreased energy and lethargy
- Loss of appetite and weight loss
- Joint pain and swelling
- Fever in acute cases
- Neurological signs including paresis and ataxia if spinal compression occurs
Diagnosis of Canine Brucellosis
Diagnosing canine brucellosis presents significant challenges for veterinarians due to the variable clinical presentation and limitations of available diagnostic tests. A definitive diagnosis requires demonstration of the causative organism, though this is not always possible in clinical practice.
Serological Testing
Serological tests detect antibodies against Brucella canis in the dog’s blood. However, these tests can produce both false positive and false negative results, complicating diagnosis. Chronic infections may test negative despite active infection, while recovered dogs may maintain antibodies for extended periods.
Approved screening tests include:
- Rapid slide agglutination test (RSAT)
- 2-mercaptoethanol rapid slide agglutination test (2ME-RSAT)
- Tube agglutination test (TAT)
- Agar gel immunodiffusion test (AGID)
- Immunofluorescent antibody test (IFA)
- Enzyme-linked immunosorbent assay (ELISA)
- Canine brucella multiplex assay (CBM)
Bacteriological Isolation
The gold standard for diagnosis remains bacteriological isolation and identification of Brucella canis. Cultures are typically obtained from blood, seminal fluid, urine, vaginal discharge, lymph nodes, prostate tissue, spleen, bone marrow, and liver. Multiple samples taken over several days increase the likelihood of successful isolation, as bacteremia can be intermittent. Culture plates are examined on days 3, 6, and 9 of incubation, with special media often supplemented with polymixin B and bacitracin to inhibit contaminating organisms.
Polymerase Chain Reaction (PCR)
PCR testing can detect bacterial DNA in various body fluids and tissues, offering another diagnostic method with improved sensitivity and specificity compared to some serological tests.
Diagnostic Considerations
Routine laboratory tests such as complete blood counts, serum biochemistry, and urinalysis typically yield normal or nonspecific results. A comprehensive diagnostic approach often requires combining multiple test methods, and in some cases, a definitive diagnosis cannot be reached despite clinical suspicion. Veterinarians may recommend sequential testing over time, as early infections may not produce detectable antibodies.
Treatment Options
Canine brucellosis is considered an incurable disease in dogs, making treatment decisions complex and often controversial. No universally accepted, completely effective treatment protocol exists that can reliably eradicate the infection.
Antibiotic Treatment
Brucella canis are intracellular bacteria, residing within host cells where antibiotics cannot reach them adequately. The bacterium is sensitive to relatively few antibiotics, and bacteria can persist inside cells and tissues even after bloodstream bacteria have been eliminated, leading to frequent relapses.
Various antibiotic protocols have been attempted, including:
- Oral tetracycline (30 mg/kg) twice daily for 28 days combined with intravenous streptomycin (20 mg/kg) once daily for 14 consecutive days
- Oral tetracycline (30 mg/kg) three times daily for 30 days with intramuscular streptomycin on alternating days
- Minocycline (10 mg/kg) twice daily combined with intramuscular streptomycin (4.5 mg/kg) for 7 days
- Long-acting oxitetracycline (20 mg/kg) intramuscularly once weekly for 4 weeks with daily streptomycin injections for the first week
- Enrofloxacin protocols lasting 4 weeks
While some treatment regimens have achieved variable success rates, with some dogs testing negative after therapy, relapse is common. Success rates vary widely, and even aggressive antibiotic combinations rarely eliminate infection completely.
Spaying and Neutering
Surgical removal of reproductive organs significantly reduces bacterial shedding, particularly through reproductive secretions. However, this procedure does not cure the infection, and the dog remains infected systemically. Spaying or neutering is often recommended as an adjunctive measure to reduce transmission risk rather than as a curative treatment.
Supportive Care and Monitoring
Dogs undergoing antibiotic treatment require lifelong monitoring and periodic retesting to detect recurrence of bacteremia. Symptomatic treatment may address specific complications such as discospondylitis-related pain or uveitis. However, treating infected dogs requires:
- Strict isolation from other dogs to prevent transmission
- Regular veterinary surveillance testing
- Compliance with state and local regulations, which vary significantly
- Long-term commitment to management protocols
Euthanasia as a Management Option
Many regions do not attempt treatment and recommend euthanasia either as a treatment choice or regulatory requirement. This approach addresses concerns regarding zoonotic transmission and the practical inability to reliably cure the infection. However, this recommendation remains controversial, as human infection from dogs appears relatively rare.
Zoonotic Risk and Human Health
Canine brucellosis poses a potential zoonotic risk, meaning infected dogs can transmit the disease to humans. The bacterium can be transmitted through contact with infected reproductive fluids, tissues, urine, and feces. People exposed to infected material, particularly those handling infected placental tissue, aborted fetuses, or reproductive secretions, face potential infection risk.
However, human infection from dogs appears uncommon compared to transmission from livestock. When humans do become infected, brucellosis is typically treatable with long-term antibiotic therapy, though the infection may persist despite treatment. People should exercise appropriate precautions when handling infected dogs or their body fluids, including wearing protective equipment and practicing thorough hand hygiene.
Management and Prevention
Preventing canine brucellosis requires multiple strategies:
- Screening all breeding animals before mating with appropriate serological testing
- Quarantining newly acquired dogs and testing before introducing to other animals
- Practicing careful hygiene when handling potentially infected materials
- Isolating infected dogs from other animals, particularly intact males and females
- Educating owners about transmission risks and appropriate precautions
- Following state and local regulations regarding testing and management of infected animals
Special Considerations for Adoption
Prospective adoptive owners should be aware that dogs with a history of brucellosis exposure or confirmed infection require special management. Many shelters and rescue organizations test animals before adoption. Adoptive owners should discuss test results thoroughly with veterinarians and understand the long-term implications of adopting an infected animal, including potential transmission risks to other pets and household members.
Frequently Asked Questions
Q: Can canine brucellosis be completely cured?
A: Canine brucellosis is considered an incurable disease. While antibiotics may reduce bacterial load and clinical signs, the infection typically persists despite treatment, and relapses are common.
Q: How is canine brucellosis transmitted between dogs?
A: The disease spreads primarily through direct contact with reproductive fluids, vaginal discharge, seminal fluid, urine, and contaminated tissues or environments. Ingestion of infected material is another transmission route.
Q: Can humans contract brucellosis from infected dogs?
A: Yes, humans can contract brucellosis from infected dogs through contact with reproductive fluids, tissues, or other body secretions. However, human infection from dogs appears relatively rare.
Q: What is the prognosis for a dog diagnosed with brucellosis?
A: The prognosis is guarded. Most infected dogs remain infected for life despite treatment efforts. Management focuses on reducing shedding and preventing transmission rather than achieving cure.
Q: Are there breed predispositions to canine brucellosis?
A: Brucellosis can affect any breed or mixed breed dog. However, it is most common in breeding populations, particularly in kennels and breeding facilities.
Q: How long can an infected dog shed bacteria?
A: Infected dogs typically shed bacteria continuously or intermittently for life. Bacteremia usually persists for approximately six months before becoming intermittent, but the dog remains infected indefinitely.
Q: What diagnostic tests are most reliable for canine brucellosis?
A: Bacteriological culture remains the gold standard, though it is not always successful. Serological tests are commonly used but can produce false positives and negatives. PCR testing offers good sensitivity and specificity.
Q: Should infected dogs be spayed or neutered?
A: Yes, spaying or neutering is recommended to reduce bacterial shedding through reproductive secretions, though it does not cure the infection. This procedure is often required by regulatory agencies.
References
- Brucella canis 2004 — University of Florida Small Animal Hospital. 2021. https://smallanimal.vethospital.ufl.edu/wordpress/files/2021/04/Brucella-canis-2004-ARS.pdf
- Canine Brucellosis — Cornell University College of Veterinary Medicine. Accessed November 2025. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/canine-brucellosis
- Canine Brucellosis: Information for Adoptive Owners — Minnesota Department of Health. Accessed November 2025. https://www.health.state.mn.us/diseases/brucellosis/caninebrucellosisadopt.html
- Brucellosis in Dogs – Reproductive System — Merck Veterinary Manual. Accessed November 2025. https://www.merckvetmanual.com/reproductive-system/brucellosis-in-dogs/brucellosis-in-dogs
- Veterinary Guidance for Brucellosis — Centers for Disease Control and Prevention. Accessed November 2025. https://www.cdc.gov/brucellosis/hcp/animals/index.html
- Brucellosis in Dogs — Blue Cross. Accessed November 2025. https://www.bluecross.org.uk/advice/dog/health-and-injuries/brucellosis-in-dogs



